The clinical significance of CTC enrichment by GPC3-IML and its genetic analysis in hepatocellular carcinoma

Abstract

The combination of immunomagnetic separation of CTCs and anti-tumor marker identification technology can be regarded as a new technology of CTCs detection in peripheral blood of patients with HCC. Trial registration EHBHKY2020-k-024. Registered 17 August 2020-Retrospectively registered.